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Abstract
The DNTM3A and DNMT3B de novo DNA methyltransferases (DNMTs) are responsible for setting genomic DNA methylation
patterns, a key layer of epigenetic information. Here, using an in vivo episomal methylation assay and extensive bisulfite
methylation sequencing, we show that human DNMT3A and DNMT3B possess significant and distinct flanking sequence
preferences for target CpG sites. Selection for high or low efficiency sites is mediated by the base composition at the 22
and +2 positions flanking the CpG site for DNMT3A, and at the 21 and +1 positions for DNMT3B. This intrinsic preference
reproducibly leads to the formation of specific de novo methylation patterns characterized by up to 34-fold variations in the
efficiency of DNA methylation at individual sites. Furthermore, analysis of the distribution of signature methylation hotspot
and coldspot motifs suggests that DNMT flanking sequence preference has contributed to shaping the composition of CpG
islands in the human genome. Our results also show that the DNMT3L stimulatory factor modulates the formation of de
novo methylation patterns in two ways. First, DNMT3L selectively focuses the DNA methylation machinery on properly
chromatinized DNA templates. Second, DNMT3L attenuates the impact of the intrinsic DNMT flanking sequence preference
by providing a much greater boost to the methylation of poorly methylated sites, thus promoting the formation of broader
and more uniform methylation patterns. This study offers insights into the manner by which DNA methylation patterns are
deposited and reveals a new level of interplay between members of the de novo DNMT family.
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Introduction
Cytosine DNA methylation, which is primarily focused at
symmetrical CpG sites in mammalian cells, represents a critical
epigenetic mark broadly associated with silent genomic regions.
Repeated DNA elements such as dispersed transposon-derived
repeats or heterochromatin-associated pericentric satellite repeats
are heavily methylated, highlighting the primordial role of DNA
methylation as a genome defense mechanism [1]. Cytosine DNA
methylation is also essential for development [2,3] and contributes
to the regulation of gene expression through differentiation [4–6].
Once DNA methylation is established on both DNA strands at a
CpG site, it is propagated with high fidelity at each cell division
[7]. This stems directly from the fact that hemi-methylated CpG
sites, a key intermediate generated by replicating through a fully
methylated CpG sequence, are preferentially methylated back to a
fully methylated state by the maintenance DNA methyltransferase
DNMT1 [8,9] in association with other interacting factors such as
UHRF1 [10,11]. Thus, DNA methylation profiles represent an
important form of epigenetic memory.
Much progress has been made in recent years in our
understanding of how cytosine DNA methylation patterns are
established during development. This de novo methylation function
is assigned primarily to the DNMT3 family of DNA methyltrans-
ferases (DNMTs) [9]. This family comprises the two active
DNMT3A and DNMT3B enzymes, which are highly expressed at
specific developmental times in germ cells and during early
development, and mediate genome-wide acquisition of DNA
methylation. In vivo, DNMT3A and DNMT3B possess both
overlapping and specific targets. DNMT3A is particularly required
for the methylation of imprinted genes and dispersed repeated
elements, such as retrotransposons, while DNMT3B specializes in
the methylation of pericentric satellite repeats [3,12–14]. The
DNMT3L protein, a non-catalytic accessory factor, also serves as
an important structural and functional accessory factor for almost
all types of de novo DNA methylation, particularly in germ cells
[15,16,17].
The mechanisms by which specific DNA methylation patterns
are instructed by DNMT3A, DNMT3B and DNMT3L in the
mammalian genome are currently unclear. Multiple studies have
indicated that chromatin composition and modification are key in
setting the accessibility of certain genomic loci to the DNA
methylation machinery. For instance, DNMT3L was proposed to
focus DNA methylation away from CpG island promoter regions
by discriminating against binding to nucleosomes marked by
trimethylation at lysine 4 on histone H3 [5,18,19]. Likewise, recent
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data indicate that the presence of the H2A.Z variant is protective
against DNA methylation in the model plant organism Arabidopsis
thaliana [20]. Other mechanisms, such as recruitment of the de novo
methylation machinery by direct association with various DNA
binding proteins [21–23] or possibly by small non-coding RNAs
[24,25], are also likely to operate.
In this study we addressed the possibility that the human
DNMT3A and DNMT3B enzymes possess an intrinsic prefer-
ence for certain DNA sequences flanking their target CpG site.
This notion is supported by the concept that the catalytic
domains of mammalian DNMTs have evolved from bacterial
methyltransferases, many of which are sequence-specific modify-
ing enzymes [9]. Moreover, recent genome-wide bisulfite
sequencing efforts have revealed clear local sequence preferences
for cytosine methylation in A. thaliana, an organism that harbors
two de novo DNA methyltransferases distantly related to the
mammalian DNMT3A and DNMT3B enzymes [26,27]. Finally,
biochemical approaches using purified DNMTs in in vitro
methylation reactions on naked DNA templates have also hinted
at the fact that the mammalian DNMT3A and DNMT3B
enzymes might possess an intrinsic flanking sequence preference
[28,29]. However, no specific consensus could be readily derived
from these studies.
Here we have used a well-described episomal DNA methylation
assay [30,31] to determine whether the full-length human
DNMT3A and DNMT3B enzymes show any flanking sequence
preference in vivo. For this, we used human HEK293c18 cells,
which show little to no endogenous de novo methylation activity,
and co-transfected target episome DNA together with expression
vectors for DNMT3A and DNMT3B in the presence or absence
of the DNMT3L protein. The resulting methylation patterns were
then determined at various test regions on the episome using
bisulfite methylation sequencing and further validated at two
additional targets. Our data clearly indicate that DNMT3A and
DNMT3B show significant and distinct flanking sequence
preferences and reveal a novel and unexpected role of DNMT3L
in modulating DNA methylation pattern formation.
Results
An assay to measure de novo methylation preferences in
vivo
The episomal methylation assay [30] offers a powerful and
versatile tool for measuring DNA methylation in human cells in
culture. This assay revolves around the use of unmethylated, stably
replicating minichromosomes that are transfected in HEK293c18
cells together with expression vectors for the DNMT(s) of interest.
Conveniently, HEK293c18 cells show little if any endogenous de
novo methylation but efficiently carry out maintenance methylation
[30]. Thus, the de novo methylation patterns established on these
target episomes by exogenous DNMT(s) expressed in these cells
are stably maintained for prolonged periods of time. Methylation
patterns can then be detected at nucleotide resolution using
bisulfite methylation sequencing [32]. Here we analyzed DNA
methylation at four distinct regions carried on episomal constructs.
All regions fit a strict operational definition for a CpG island,
namely GC content .55% and a ratio of observed versus
expected CpG sites ratio.0.8 [33]. Focusing on CpG-rich regions
enabled us to maximize the range of sequence flanks analyzed;
altogether 271 distinct CpG sites were studied.
To validate these episomal constructs as a good tool for
determining the intrinsic sequence preference of the human
DNMT3A and DNMT3B enzymes, we wanted to ensure that de
novo methylation could not trigger DNMT1-mediated ‘‘spreading’’
effects around pre-methylated sites [34]. If spreading were to
occur, it would diminish our ability to discern true de novo activity
by the de novo enzymes from DNMT1-mediated activity. To test
this, we methylated the pFC19 episome in vitro with the HhaI DNA
methyltransferase and transfected the DNA in HEK293c18 cells.
After 7 days, the episomal DNA was recovered by Hirt harvest and
DNA methylation patterns were determined using bisulfite
methylation sequencing. The methylation pattern on the input
DNA prior to transfection was also determined for comparison.
The data clearly show that methylation patterns were faithfully
maintained without significant modification from the initial
pattern (data not shown). Thus, DNMT1 does not appear to lead
to ‘‘spreading’’ effects in this sytem. We also transfected the pre-
methylated episomes together with expression vectors for
DNMT3A or DNMT3B to determine if pre-methylated sites
might attract the de novo enzymes to their immediate vicinity
(‘‘seeding’’ or ‘‘clustering’’ effects). We determined the methylation
patterns and compared them to the patterns obtained with
unmethylated episomes and observed no significant changes (data
not shown). This indicates that pre-existing CpG methylation does
not stimulate DNMT3A or DNMT3B activity, in agreement with
another independent study [35].
Finally, since our episomes are generated in E. coli and therefore
carry Dam methylation (N6 Adenine methylation at GATC
sequences) and Dcm methylation (C5 methylation at the internal
cytosine in CCA/TGG sequences), we verified that such non-CpG
methylation marks do not modify the CpG methylation patterns
laid by DNMT3A or DNMT3B. For this, episome DNA was
extracted from dam2, dcm2, and dam2 dcm2 E. coli strains and used
for transfections together with expression vectors for DNMT3A or
DNMT3B. The distribution of methylated sites, as judged by
Southern blots after digestion with methyl-sensitive restriction
enzymes, did not detectably vary (data not shown), indicating that
pre-existing non-CpG methylation does not influence the activity
of the de novo enzymes. Similar observations have been reported
[35]. The presence of 5-methylcytosine at Dcm sites, however,
provided us with the ability to track whether a particular DNA
strand has been newly synthesized in human cells upon replication
Author Summary
The methylation of cytosine bases in DNA represents an
extra layer of heritable biological information necessary for
regulating gene expression and ensuring genomic stability
in mammals. In this paper, we examine the function of the
proteins responsible for laying down the initial DNA
methylation patterns in the human genome. These
proteins, called de novo DNA methyltransferases (DNMTs),
comprise two active enzymes, DNMT3A and DNMT3B, and
one stimulatory factor, DNMT3L. Our study clearly estab-
lishes that DNMT3A and DNMT3B do not methylate DNA at
random but rather that they show strong and distinct
preferences for their target sites in vivo. These preferences
lead to the deposition of unique and reproducible patterns
of methylation and may have contributed to shaping
segments of the human genome. In contrast, we show
that DNMT3L stimulates DNA methylation mostly at sites
that are poorly methylated on their own, thus leading to
patterns that are more uniform. This modulation is
proposed to result from DNMT3L anchoring the DNA
methylation machinery onto chromatin, the physiological
form under which DNA exists in our cells. This study
furthers our understanding of how genomic DNA meth-
ylation patterns are established in vivo.
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of the episome or corresponds to an ‘‘old’’ bacterial DNA strand
that was transfected in. Indeed, non-CpG methylation is not
maintained in human cells and newly synthesized DNA strands
were consistently devoid of dcm methylation.
DNMT3A shows a significant flanking sequence
preference for methylating DNA in vivo
Methylation of the target minichromosome by DNMT3A was
analyzed by bisulfite methylation sequencing at two test regions
(Hygro and pBR – See Material and Methods) on both DNA
strands. In total, 20,352 CpG sites were sequenced for the
DNMT3A sample, representing over a 100-fold coverage of all
available sites. For most regions, the methylation at various CpG
sites was not uniform but rather showed clear evidence for high
and low methylation sites, as evidenced for the pBR Top strand
region (Figure 1A). While the overall methylation efficiency on
that strand was 15.3%, the methylation was not evenly distributed
between all 48 CpG sites, leading to the formation of a clear
pattern characterized by high and low efficiency sites. Site # 3, for
instance, was methylated with an efficiency of 28.5% while site #
31 was methylated with an 11-fold lower efficiency of 2.6%. The
presence of hotspots and coldspots for DNA methylation and the
overall pattern of DNA methylation resulting from DNMT3A
activity was reproducible in a completely independent biological
replicate. For example, Figure 1B shows that when CpG sites were
ranked according to their individual methylation efficiencies in
each sample, a clear positive correlation is observed between the
two independent replicates. This reflects the fact that top
methylation sites (low ranks) remain highly methylated in both
samples while bottom methylation sites (high ranks) show
consistently poor methylation in both samples. Indeed, 6 out of
the 10 top CpG sites in sample 1 also belonged to the top 10 sites
in sample 2. Conversely, 7 out of the 10 bottom CpG sites in
sample 1 also belonged to the bottom 10 sites in sample 2 for that
particular region. Similar observations of consistent high and low
efficiency sites were made at the Hygro region with individual
variation in methylation efficiencies of up to 6-fold (data not
shown).
Consistent with the presence of endogenous maintenance DNA
replication in HEK293 cells, the methylation patterns observed at
each region were mostly symmetrical between the two DNA
strands. As shown in Figure 1C, a strong correlation of
methylation efficiencies is observed across the two strands of the
pBR region. This observation has implications for our ability to
properly identify and score the flanking sequences of high and low
methylation sites. Indeed, the presence of a methylation hotspot on
one strand should lead to the observation of a high methylation
site on the other strand due to maintenance methylation.
Therefore, some sites that appear as methylation hotspots may
not directly correspond to a hotspot but may be located across a
hotspot on the other strand. In contrast, this predicts that
methylation coldspots should correspond to low methylation
efficiency sites on both DNA strands, as observed.
To determine if the high and low methylation sites observed as a
result of DNMT3A activity could be explained by a potential
flanking sequence preference, we focused on the sequences
flanking the 10% most methylated CpG sites and the 10% least
methylated CpG sites at the pBR and Hygro regions. For this, all
CpG sites within each region were ranked according to their
respective methylation efficiencies and the flanking sequences
extracted on each side of the target CpG site. The sequences were
then systematically aligned with each other either in direct or
reverse-complement orientation to identify regions of similarity in
each class. In the case of DNMT3A, it rapidly became apparent
that methylation hotspots were likely to share a T residue at the
22 position and a C residue at the +2 position from the target
CpG sites (Figure 2A). The over-representation of the T and C
residues at these positions over the average sequence composition
of the regions under study was statistically significant with p-values
of 5610211 and 261023, respectively. Interestingly, low efficiency
sites, which on average were methylated at a 5.3-fold reduced
efficiency compared to high sites, also showed statistically
significant enrichment for adenine residues at position 22
(Figure 2B), indicating that this position is particularly important
for discriminating between a good and bad flank. Examination of
up to 12 positions on each side of the target CpG site revealed that
positions 22 and +2 were the only positions to show strong
statistical significance (data not shown). Similar results were
observed when the shorter DNMT3A2 isoform [36] was used as
judged from the strong correlation of methylation efficiencies at
individual CpG sites (Figure S1). As expected, no enrichment was
observed when the entire set of CpG sites analyzed here was
aligned (Figure 2C).
DNMT3A shows strong intrinsic flanking sequence
preference in vitro consistent with in vivo observations
To determine if the flanking sequence preference observed for
DNMT3A in HEK293 cells corresponds to an intrinsic enzymatic
preference, we used the purified catalytic domain of DNMT3A
and performed in vitro DNA methylation reactions. The resulting
methylation at the pBR region was analyzed by bisulfite
sequencing on both DNA strands. As observed in vivo, the
methylation patterns indicated clear preference for some sites over
others with a 15-fold maximal range between high and low sites
(data not shown). When the sequences flanking the 15% top and
bottom sites were extracted and aligned, a pattern similar to the
one observed in vivo emerged. Top methylated sites (average
methylation efficiency 88.2%) tended to carry a T at position 22
and a C at position +2 (Figure 2D). By contrast, the least
methylated sites (average methylation efficiency 13.4%) showed an
enrichment for A or G residues at the 22 position and a G at
position +2 (Figure 2E). Thus, the sequence composition at the 22
and +2 positions appears critical in selecting for a good or bad
flank for DNMT3A in vivo and in vitro. Moreover, since in vitro
methylation patterns are not compounded with any maintenance
methylation, this indicates that the DNMT3A preference was
properly assigned in vivo and that this preference represents an
intrinsic property of the catalytic site of the enzyme. Interestingly,
nearly 25% of all methylated cytosines observed in vitro were found
in CpA and CpT contexts, clearly showing that DNMT3A is
capable of non-CpG methylation activity, in agreement with
previous studies [37,38]. Highly methylated non-CpG sites also
showed an enrichement for a T at the 22 position (data not
shown). The high preponderance of non-CpG methylation in vitro
is in contrast to the situation observed in vivo as episomal substrates
showed little to no non-CpG methylation (data not shown). This is
likely due to the fact that methylated non-CpG sites are not
maintained upon replication by DNMT1.
In vivo methylation by DNMT3B reveals a significant
flanking sequence preference distinct from DNMT3A
The DNMT3B in vivo methylation patterns were next analyzed
in the same manner as DNMT3A. In total 20,203 CpG sites were
sequenced for the DNMT3B1 sample, again representing over a
100-fold coverage. Detailed inspection of the patterns deposited by
DNMT3B at the pBR and Hygro regions revealed that the
patterns showed distinct and reproducible high and low frequency
De Novo Methylation Pattern Formation
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methylation sites (Figure 3A). Importantly, the DNMT3B patterns
were different than those for DNMT3A with distinct CpG
positions corresponding to hotspots and coldspots (compare
Figure 3A to Figure 1A). Compared to DNMT3A, DNMT3B
showed an even greater discrimination between high and low sites:
a 34-fold difference was observed between the highest (29.3%
methylation efficiency) and lowest (0.86%) sites on the pBR
bottom strand. This indicates that, compared to DNMT3A,
DNMT3B preferentially methylates, and avoids, different flanking
sequences. As observed for DNMT3A, the overall DNA
Figure 1. DNMT3A methylation patterns are characterized by reproducible and symmetrical high and low efficiency methylation
sites. A. This panel represents the DNA methylation patterns deposited by DNMT3A at the pBR top strand region as determined by bisulfite
methylation sequencing. Each horizontal line corresponds to an independent DNA molecule while each vertical line corresponds to one of the 48
CpG sites in this region. Black squares indicate CpG methylation while white squares represent absence of methylation. The arrows indicate the two
sites with the greatest and least methylation frequencies, respectively, along with their corresponding methylation frequencies. B. Two independent
in vivo samples were analyzed for their DNA methylation patterns and the CpG sites were ranked according to their methylation efficiency. The ranks
observed at each of the 48 CpG sites were then plotted against each other in one sample versus another. Overall, a good correlation exists between
methylation ranks, indicating that the methylation patterns for DNMT3A are reproducible. C. The individual methylation efficiency at each CpG site
along the pBR322 region are plotted for both top and bottom DNA strands. The patterns observed are clearly symmetrical across DNA strands.
doi:10.1371/journal.pgen.1001106.g001
De Novo Methylation Pattern Formation
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methylation patterns were symmetrical across both DNA strands
(Figure 3B).
To extract the flanking sequence preference for DNMT3B, we
focused on the 10% most methylated and the 10% least
methylated CpG sites at the two test regions and aligned these
sites with respect to the central CpG site. DNMT3B hotspots
revealed an enrichment for a T residue at position 21 and a G
residue at position +1 with p-values of 261023 and 761025,
respectively. Coldspots, by contrast, showed a strong enrichment
for a C residue at position +1 with a p-value of 161028
(Figure 4A). Thus, unlike DNMT3A, which discriminates between
flanks by the composition of the 22 and +2 flanks, DNMT3B
appears to respond mostly to the sequence composition at the 21
and +1 positions.
To validate these observations, we sought to determine whether
methylation by DNMT3B would be more prevalent at 59-CCGG-
39sites, which are recognized by the methylation-sensitive HpaII
enzyme, than at 59-GCGC-39 sites, which are recognized by the
methylation-sensitive HhaI enzyme. Our observation that a G at
the +1 position is a hallmark of high efficiency sites while a C in
this position is highly enriched in low efficiency sites predicts this
outcome. Upon cleavage of our Hirt harvest episomal vector with
HpaII and HhaI, the resulting DNA fragments were separated by
gel electrophoresis and the DNA methylation patterns were
revealed by Southern blotting. As shown in Figure 4B, high
molecular weight bands corresponding to the methylation of
almost all available sites can be readily observed upon digestion
with HpaII. By contrast, we reproducibly failed to detect such high
mobility species upon cleavage by HhaI even in the presence of the
stimulatory factor DNMT3L, indicating that HhaI sites remained
available for cleavage and therefore were unmethylated. This
indicates that HhaI sites, which carry a C at the +1 position, are
poorly methylated in contrast to HpaII sites, which carry a G at
the +1 position, in agreement with our sequencing data. As also
predicted by our analysis, methylation of episomal DNA by
DNMT3A did not lead to any measurable distinction in the
cleavage efficiency by HpaII or HhaI (Figure 4B). These
observations therefore validate our sequencing data using an
independent method and indicate that most of the variation in
methylation efficiencies for DNMT3B is indeed captured by the
21 and +1 positions from the target CpG site since HhaI is
insensitive to all other positions. We also independently examined
DNA methylation activity for the active DNMT3B2 splice isoform
and observed that the flanking sequence preference for
DNMT3B2 was essentially unchanged compared to the full-length
DNMT3B1 protein (Figure S1).
Validation of sequence preference at mammalian CpG
islands
While the test regions used so far correspond broadly to CpG
islands, we wished to validate the preferences observed using
sequences directly of human origin. For this, two human CpG
islands were cloned into episomal constructs and used as sequence
targets.
The first region analyzed corresponded to a 539 bp portion of
the imprinted and maternally methylated SNRPN CpG island
carrying 37 CpG sites. This region, while GC-rich overall, shows a
strong strand asymmetry in the distribution of guanine and
cytosines outside of CpG sites such that one strand is highly G-rich
and the other highly C-rich, a property referred to as GC skew.
Interestingly, the overall methylation efficiencies of the two strands
were significantly different (DNMT3A: C-rich 18.5%/G-rich
31.5%; DNMT3B: C-rich 9.7%/G-rich 21.7%) despite the
presence of efficient maintenance methylation at other regions
tested on the same episomes. This suggests that the de novo enzymes
are recruited preferentially to the G-rich strand and/or that the
maintenance machinery has difficulty maintaining the methylation
patterns at these regions (an intrinsic bias in our ability to detect
highly methylated C-rich strands is unlikely as such molecules can
be efficiently recovered upon in vitro methylation; data not shown).
Inspection of the patterns deposited on both strands revealed that
the G-rich strand was also more uniformly methylated (maximal
fold difference between the most and least methylated sites: 2.6
and 3-fold for DNMT3A and DNMT3B, respectively) than the C-
Figure 2. DNMT3A shows selectivity for residues flanking the
target CpG site at positions22 and +2. The sequences flanking the
most (panels A, D) and least (panels B, E) methylated sites for DNMT3A
were extracted and aligned as described in the text. Residues that were
enriched at any position in the 4 base-pairs surrounding the target CpG
site on each side (x-axis) are represented in the Logos format whereby
sequence enrichment at each position is indicated by the size of each
letter in bits (y-axis; 2 reflects perfect conservation while 0 reflects a
random distribution). The corresponding P-values measuring the
enrichment of a given residue over the input DNA sequence are
indicated for positions showing significant preference. Information was
derived either from our episomal assay in vivo (panels A and B) or using
purified DNMT3A complexes in vitro (panels D and E). Panel C
corresponds to the entire set of CpG sites analyzed here – these sites
showed no intrinsic sequence enrichment.
doi:10.1371/journal.pgen.1001106.g002
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rich strand (maximal fold difference between the most and least
methylated sites: 5.6 and 23-fold for DNMT3A and DNMT3B,
respectively).
When focusing on the C-rich strands, which show variation in the
patterns, we noted that for DNMT3A (81 independent molecules
were analyzed), two of the the top three sites (average methylation
efficiency 33%) displayed a T at position 22 and two displayed a C
at position +2. By contrast, the bottom five sites (average methylation
efficiency 8.9%) were flanked by either an A at position 22 (three
cases out if five) or a G at position +2 (2 cases out of five) (Figure S2).
Thus, the variation in methylation efficiencies observed at the
SNRPN region for DNMT3A recapitulated the preference observed
Figure 3. DNMT3B shows significant sequence preference distinct from DNMT3A. A. This panel represents the DNA methylation patterns
deposited by DNMT3B along the pBR top strand region. Symbols are as described above. Note that the overall pattern of DNA methylation is
strikingly different from the one observed for DNMT3A (Figure 1A). The most and least methylated sites in this region are indicated with an arrow
along with their respective methylation frequency. B. The individual methylation efficiency at each CpG site along the pBR322 region are plotted for
both top and bottom DNA strands. As observed for DNMT3A, the patterns are clearly symmetrical across DNA strands.
doi:10.1371/journal.pgen.1001106.g003
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at our test regions. Likewise for DNMT3B (88 independent
molecules were analyzed), six out of the seven bottom sites (average
methylation efficiency 2.6%) carried a C at position +1, while only
one out of the four top sites (average methylation efficiency 20.9%)
carried a C at this position (Figure S2).This is again compatible with
the observations reported above for test regions.
We also analyzed DNA methylation patterns at the CpG island
from the TIMELESS promoter which was cloned in our episomal
construct in place of the SNRPN region. In this case, the
methylation of 12 CpG sites were investigated by quantitative
methylation pyrosequencing. Upon expression of DNMT3A,
methylation patterns were remarkably consistent over three
independent experiments and showed only little variation: the
maximal fold difference in methylation efficiencies between the
most and least methylated sites was 1.8-fold (data not shown).
Thus little information could be derived. In the case of DNMT3B,
however, a highly reproducible pattern could also be detected and
the most and least methylated sites showed an average 4.4-fold
difference in methylation efficiencies (Figure 5). Strikingly, site
#10, the most methylated site in this sequence corresponded to
the predicted hotspot TCGG, while the second most methylated
site (Site #1) corresponded to an HpaII site (CCGG), also
predicted to represent a hotspot. Furthermore, the least methyl-
ated site, site #3, mapped onto the predicted coldspot GCGC
(HhaI site), while the second least methylated site (Site #9)
mapped to the palindromic CACGTG sequence. Sites with
intermediate methylation efficiencies did not fit to either consensus
motifs for predicted high and low sites. Altogether, this suggests
that the sequence preferences derived from test regions do apply
broadly to various sequences regardless of their origin.
Evidence for altered distribution of hotspot and coldspot
sequences in human CpG islands
In the euchromatic portion of the human genome, the CpG
dinucleotide is mostly confined to CpG islands. Within these loci,
Figure 4. DNMT3B shows selectivity for residues flanking the
target CpG site at positions 21 and +1. A. The flanking sequence
preference for DNMT3B was analyzed from the 10% top (left side) and
10% bottom (right) methylation sites, as described in the text.
Conservation of particular residues at each 4 positions flanking the
target CpG site is represented as Logos diagrams. B. Methylation-
sensitive restriction enzymes confirm sequencing data. Methylation
sensitive restriction enzyme digestion of DNMT3A and DNMT3B
samples followed by Southern blotting reveals the methylation status
at HhaI and HpaII sites. For DNMT3B, HhaI sites (59-GCGC-39) are
predicted to correspond to low efficiency sites. By contrast, HpaII sites
(59-CCGG-39) are predicted to correspond to high efficiency sites. As
shown here, even in the presence of the stimulatory factor DNMT3L,
DNMT3B cannot catalyze the complete methylation of the target
episomal DNA at HhaI sites (left panel – asterisk). By contrast, DNMT3B
can promote complete methylation at HpaII sites (right panel). Also as
predicted, DNMT3A shows similar methylation at both sites.
doi:10.1371/journal.pgen.1001106.g004
Figure 5. Validation of the DNMT3B sequence preference at
the human TIMELESS CpG island. The methylation frequencies
observed at each CpG site are shown relative to the average frequency
observed for the region (i.e. a value of 2 would indicate that the
frequency at a given site is two-fold above average). Each bar
represents the average of three independent experiments; error bars
indicate standard deviation. Hotspots and coldspots are indicated and
are as expected from the sequence preferences derived from test
regions.
doi:10.1371/journal.pgen.1001106.g005
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one can distinguish between two classes of islands: ‘‘specific’’ CpG
islands serve as promoters and are seldom methylated; ‘‘weak’’
CpG islands are located in the bodies of genes or in intergenic
regions and are often methylated and silent [39]. It is tempting to
speculate that the relative unmethylated state of ‘‘specific’’ CpG
islands might be explained at least in part by an under-
representation of DNA methylation hotspots and/or perhaps an
over-representation of DNA methylation coldspots. In contrast,
one might expect that weak CpG islands might show little
evidence for selection of particular sequence motifs.
To evaluate this possibility, we used the R’MES statistical
package, which uses Markovian models to evaluate the excep-
tionality of motif (or ‘word’) frequency in DNA. When looking at
6-letter words under the M1 model, which analyzes a given DNA
sequence based on mono- and di-nucleotide frequencies, we first
determined that words fitting the NNCGNN consensus showed a
much greater range of over- or under-representation in the
‘‘specific’’ set compared to the ‘‘weak’’ set of CpG islands (data not
shown). Interestingly, we determined that NGCGCN sites, which
are predicted to represent DNMT3B methylation coldspots,
showed significant over-representation in the set of ‘‘specific’’
CpG islands, but not in ‘‘weak’’ CpG islands in an M1 model
(Figure 6). By contrast, we determined that NTCGGN sites, which
are predicted to represent DNMT3B DNA methylation hotspots,
tended to be under-represented in the set of ‘‘specific’’ islands
(Figure 6). This under-representation was much less visible in the
Figure 6. Human CpG islands show evidence of selection at methylation signature motifs. The distribution of predicted DNMT3B
methylation coldspots (59-NGCGCN-39, top) and hotspots (59-NTCGGN-39, bottom) was analyzed in two datasets corresponding to all ‘‘specific’’ and
all ‘‘weak’’ CpG islands from human chromosome 1, respectively. The score on the y-axis represents the exceptionality of the frequency of a given
motif. A positive score indicates an over-representation of a motif in a given model of the sequence (the M1 model, which computes expected motifs
frequencies based on mono- and di-nucleotide frequencies was used here). A negative score indicates under-representation. A higher absolute score
value indicates a greater statistical significance (a score of 5 corresponds to a p-value of ,1026, which starts to be considered significant; a score of
10 corresponds to a p-value of ,10223).
doi:10.1371/journal.pgen.1001106.g006
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‘‘weak’’ CpG islands. Interestingly, the most under-represented
NNCGNN word in the set of ‘‘specific’’ CpG islands was 59-
TTCGGC-39, a predicted sequence hotspot for both DNMT3A
and DNMT3B. For this word, less than half of the expected
occurences could be counted (249 out of 530, respectively), which
is associated with a strong statistical significance (p-value,10234).
However, we could not detect further evidence for enrichment or
depletion based on the 22 and +2 position of NNCGNN sites.
This analysis suggests that the intrinsic flanking preference of
DNMT3B, and to a lesser extent DNMT3A, might have
contributed to shaping promoter CpG island sequence composi-
tion in the human genome.
DNMT3L focuses de novo methylation on properly
chromatinized DNA templates
Having determined the flanking sequence preference of
DNMT3A and DNMT3B on their own, we then examined the
effect of the DNMT3L protein on the formation of DNA
methylation patterns. DNMT3L, as described previously, is a
potent stimulatory factor for de novo methylation. However, at first
inspection, our data revealed only a moderate 1.5 to 2-fold
stimulation of DNA methylation by DNMT3L, which was
somewhat lower than previously observed in vivo [40,41]. Upon
closer examination of sequencing data, we noticed a significant
difference between DNA strands that had been newly synthesized
inside HEK293 cells (characterized by the fact that they lost the
original dcm bacterial methylation marks; these strands are
thereafter referred to as dcm2) and the original DNA strands
that were transfected (these strands carry the dcm bacterial marks
and are referred to as dcm+). Namely, we observed that newly
replicated DNA strands (dcm2) showed much stronger levels of
stimulation by DNMT3L than dcm+ strands, which for most
regions examined showed no significant stimulation by DNMT3L
(Figure 7). Hence, the average stimulation on dcm+ strands at the
pBR322 and Hygro regions for DNMT3A was 1.3-fold, while it
was 3.2-fold on dcm2 strands. A similar observation was made for
DNMT3B. Interestingly, this distinction between dcm2 and
dcm+ DNA strands only applied when DNMT3L was present; the
methylation efficiencies of these strands were very similar when
DNMT3A or DNMT3B were considered on their own (data not
shown).
This strongly suggests that the effect of DNMT3L is mostly felt
on newly replicated DNA strands. There are two hypotheses that
could explain this observation. One is that stimulation of DNA
methylation by DNMT3L might be mechanistically coupled to
DNA replication. The other is that DNMT3L might focus DNA
methylation towards well-chromatinized DNA templates, thus
biasing the DNA methylation machinery towards newly replicated
episomal DNA molecules that have acquired chromatin with fork
passage. No evidence exists so far for a coupling between de novo
DNA methylation and DNA replication. On the contrary,
DNMT3L clearly promotes de novo methylation in non-dividing
cell types [42]. Likewise, recent evidence shows that DNMT3L
physically binds to chromatin [18,19].
To distinguish between these two hypotheses, we devised an
experiment that allowed us to track DNMT3L stimulation as a
Figure 7. Stimulation by DNMT3L is observed primarily on newly replicated DNA strands. The overall methylation efficiencies (in
percentages) observed on both strands at the pBR322 and Hygro regions are indicated in black bars for DNMT3A (panel A) and DNMT3B (panel B).
The number of independent DNA molecules taken into account to calculate the average methylation efficiencies varied from 36 molecules to 120 per
sample. In the presence of DNMT3L, the data were broken down between dcm+ (grey bars) and dcm2 (checkered grey bars) DNA strands, as
indicated. Whether the stimulation afforded by DNMT3L was significant or not was determined by a one tailed Student t-test and is indicated
graphically (‘no’, not significant; ‘***’ P-value,0.001; ‘**’ P-value between 0.001 and 0.01; ‘*’ P-value between 0.01 and 0.05). While DNMT3L-mediated
stimulation of DNA methylation is readily observed at all tested regions on newly synthesized DNA molecules (dcm2), it is not observed in the
majority of cases for dcm+ molecules.
doi:10.1371/journal.pgen.1001106.g007
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function of replication on fully chromatinized episomes. Episomes
were transfected in HEK293c18 cells and allowed to propagate
under selective pressure through multiple rounds of replication
encompassing at least 20 cell generations. At this point the
episomes are expected to be fully chromatinized and episomal
DNA no longer carried detectable dcm methylation (data not
shown). To track the replication status of DNA strands we then
transiently transfected a vector expressing a MYC-tagged version
of the bacterial Dcm methyltransferase carrying a nuclear
localization signal to mark DNA strands in a ‘‘pulse’’ of expression.
Using Western blots, we determined that the Dcm methyltrans-
ferase was efficienctly expressed 24 hours after transfection and
remained at high levels in the cells up until ,5 days post
transfections, at which point expression rapidly declined (data not
shown).
Two days post-transfection, we extracted the genomic DNA and
verified that the DNA had become marked in that it became
extensively resistant to cleavage by EcoRII, a restriction enzyme
sensitive to dcm methylation (data not shown). In addition,
episomal DNA became re-methylated at dcm sites, as determined
by bisulfite sequencing (data not shown). This transient pulse of
Dcm expression therefore allowed us to re-mark endogenous
DNA, enabling us to track the replication status of DNA strands.
Seven days after the Dcm expression vector was first transfected,
we then introduced expression vectors for DNMT3A in the
presence or absence of DNMT3L. The resulting methylation
patterns were determined using bisulfite methylation sequencing
another seven days after transfection of DNMT vectors. Our
prediction was that if DNMT3L function is coupled to DNA
replication, then only the newly replicated dcm2molecules should
show stimulation. By contrast, if DNMT3L function is indepen-
dent from DNA replication but is sensitive to the chromatin status
of its target molecules, then both dcm2 and dcm+ molecules
should show stimulation. Consistent with this second hypothesis,
DNMT3L triggered a 6.34-fold stimulation of DNA methylation
on dcm+ molecules and a 5.76-fold stimulation on dcm2
molecules. This indicates that, as expected, DNMT3L stimulation
is not dependent upon replication, and suggests that DNMT3L
directs DNA methylation to fully chromatinized templates.
DNMT3L favors the formation of more uniform DNA
methylation patterns without altering the intrinsic
sequence preferences of DNMT3A and DNMT3B
While it is clear that DNMT3L stimulates the catalytic activity
of its partners, it remains to be determined if the stimulation is
accompanied by any change in the flanking sequence preference of
DNMT3A or DNMT3B. To determine this, we ranked CpG sites
according to their individual methylation efficiencies in the
presence and absence of DNMT3L and compared the ranks
between the two categories. DNMT3L, while it strongly stimulated
DNA methylation by DNMT3A on dcm2 strands, did not alter
the rankings of high and low efficiency sites (Figure 8A left).
Similar results were observed for DNMT3B (Figure 8A right). In
addition, DNA methylation patterns deposited in vitro by the full
length DNMT3A2 enzyme in complex with DNMT3L clearly
showed evidence of selection for suitable flanks at the 22 position
(Figure S3).Thus, it seems likely that DNMT3L does not alter the
intrinsic sequence preference of either active enzyme, consistent
with the notion that DNMT3L binds to DNA poorly [43].
We noticed, however, that the spread in the individual
methylation efficiencies between CpG sites was noticeably reduced
in the presence of DNMT3L, thus leading to the establishment of
Figure 8. DNMT3L modulates DNA methylation pattern formation by DNMT3A or DNMT3B. A. Methylation ranks observed for DNMT3A
alone (left) or DNMT3B alone (right) on the pBR322 top strand region are plotted against the corresponding methylation ranks observed when
DNMT3L is also introduced (dcm2 strands only). A clear correlation is observed, indicating that the overall hierarchy of sites is not changed (r2 values
are 0.80 for DNMT3A (left) and 0.55 for DNMT3B (right)). B. Fold stimulation exerted by DNMT3L at each individual site is plotted as a function of each
site’s corresponding methylation efficiency in the absence of DNMT3L. The sites with the lowest initial methylation in the absence of DNMT3L clearly
show the strongest stimulation, leading to the formation of more uniform DNA methylation patterns.
doi:10.1371/journal.pgen.1001106.g008
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more uniform patterns characterized by long tracks of contigu-
ously methylated sites. For instance, the range of individual
methylation efficiencies observed in the presence of DNMT3A on
the pBR bottom strand was 28-fold (Figure S4). In sharp contrast,
the corresponding range of methylation efficiencies at these sites
was 4.3-fold in the presence of DNMT3L, which represents a
significant reduction (Figures S4 and S5). Similarly, when this
analysis was performed for DNMT3B at the same region, the
maximal difference between individual sites shifts from 34-fold in
the absence of DNMT3L to 12.5-fold in its presence, a statistically
significant reduction (Figure S5). This phenomenon is explained
by the fact that the sites that show the strongest stimulation by
DNMT3L correspond to those that were the least methylated by
DNMT3A or DNMT3B on their own. This is clearly illustrated in
Figure 8B by an inverse relationship between the fold stimulation
afforded by DNMT3L at each individual CpG site and individual
methylation efficiencies in the presence of DNMT3A or
DNMT3B alone. The sites with the lowest initial methylation
showed a striking 32–35-fold increase by DNMT3L while the sites
with the greatest initial methylation only showed a 2–3-fold
increase. Altogether this shows that while DNMT3L does not alter
the intrinsic sequence preference of DNMT3A and DNMT3B, its
stimulatory effect is most felt at the sites with the initial lowest
methylation efficiency. DNMT3L therefore attenuates the intrinsic
sequence preference of DNMT3A and DNMT3B, resulting in the
deposition of more uniform methylation patterns.
Discussion
One important unanswered issue surrounding the establishment
of DNA methylation patterns relates to the individual contribution
of each member of the de novo DNA methyltransferase family to the
actual formation of the patterns in vivo. Here, we took advantage of
an episomal assay and examined de novo methylation mediated by
DNMT3A or DNMT3B (with and without DNMT3L) in human
cells using extensive bisulfite methylation sequencing. This assay
offers several advantages. The cell line that we used, which has
little or no endogenous de novo methylation activity [44], allowed us
to study the activity of exogenously expressed full-length human
DNMT3A and DNMT3B separately, an otherwise impossible task
when analyzing genomic DNA methylation profiles. Likewise,
using unmethylated episomes as substrates for DNA methylation
allowed us to ensure that the patterns deposited by each enzyme
were relatively unaffected by pre-existing parameters such as
chromatin compaction, composition, and modification states.
Such parameters are unavoidable when studying genomic
methylation patterns and strongly compound the activity of de
novo DNMTs. While representing a simpler substrate than
genomic DNA, the episomes used here are biologically relevant
in that they are self-replicating, acquire chromatin, and undergo
maintenance DNA methylation and epigenetic silencing [30,45].
In addition, episomal de novo methylation requires the SNF2-family
chromatin remodeling factor Lsh and responds to the DNMT3L
stimulatory factor just as observed at endogenous loci [40,46].
Therefore, this assay offers a useful window into the intrinsic de
novo activity of each enzyme in vivo.
Our data indicate that the human DNMT3A and DNMT3B
enzymes instruct the deposition of unique DNA methylation
patterns. These patterns are characterized by clear and reproduc-
ible high and low methylation sites distinguished by greater than
10-fold differences in individual methylation efficiencies. This
indicates that DNMT3A and DNMT3B do not methylate DNA at
random. For DNMT3A, the overall difference in methylation
efficiency between the top 10% most methylated sites and the
bottom 10% least methylated sites was 5.3-fold (Figures 1 and 2).
This difference was 8.3-fold for DNMT3B, which consistently
appeared more selective than DNMT3A in its DNA methylation
patterns (Figure 3 and 4). The selectivity of de novo methylation
measured here for human DNMT3A and DNMT3B is in
agreement with data from A. thaliana for which hotspots and
coldspots varied up to 13-fold in methylation efficiency depending
on sequence context [26,27]. Sequence alignments revealed that
specific residues were significantly over-represented at particular
positions flanking ‘‘hot’’ or ‘‘cold’’ CpG sites. Importantly, the
motifs revealed by such alignments were (i) reproducible across
independent biological replicates; (ii) reproducible across active
isoforms of DNMT3A and DNMT3B; (iii) derived from the
alignment of multiple, carefully selected, hotspots and coldspots
picked from over 270 distinct CpG sites originating from several
test regions of various provenance; (iv) recapitulated upon analysis
of DNA methylation patterns in vitro for DNMT3A; and (v)
validated by an independent enzyme-based assay for DNMT3B.
Altogether, this indicates that these motifs represent high
confidence assignments.
The motifs associated with these hotspots and coldspots showed
a clear and consistent ‘‘mirror image’’ pattern of enrichment at
specific positions. For instance, in the case of DNMT3A, highly
methylated CpG sites showed a significant over-representation of a
T at position 22, while poorly methylated sites showed
enrichment for an A at this position. To a lesser degree, hotspots
tended to show over-representation for a C at position +2 while
coldspots tended to carry a G at this position (Figure 2). A similar
observation was made for DNMT3B: hotspots were significantly
enriched for a G at position +1, while coldspots displayed a C
(Figure 4). The observation of such patterns of reciprocal
enrichment between hotspots and coldspots strongly suggests that
the positions identified in our study are key in the selection of good
or bad flanks. In the case of DNMT3B, the observation that HhaI
sites (GCGC) represent cold sites compared to HpaII sites
(CCGG) (Figure 4), additionally suggests that most of the variation
in DNA methylation efficiency was captured by the 21 and +1
positions since these restriction enzymes are not sensitive to
variation outside their recognition site. Altogether, our data
indicate that DNMT3A and DNMT3B discriminate between
good and bad flanks by responding to the sequence composition at
distinct positions around the CpG site. While DNMT3A responds
to the composition at the 22 and + 2 positions, DNMT3B
mediates its selection through the 21 and +1 positions. This likely
reflects intrinsic differences in the catalytic properties of DNMT3A
and DNMT3B and suggests that DNMT3A and DNMT3B,
despite their strong amino acid conservation over the catalytic
domain, contact DNA around the target CpG site differently.
Interestingly, the22,21, +1 and +2 positions flanking the CpG
site were the only positions to show statistically significant
deviations in their sequence composition. These observations are
in agreement with data from A. thaliana for which selection for a
good or bad flank was essentially mediated through the two
positions adjacent to the target site [26,27]. Our analysis did not
uncover any significant relationship between CpG spacing and
DNA methylation efficiency and, sites separated by 8–10 bp did
not appear more efficiently methylated. In contrast, we observed
several instances of strong methylation hotspots that were not
flanked by any CpG site within 8–10 bp. Likewise, we observed in
a few instances that the presence of a strong methylation hotspot
did not necessarily translate into similarly high methylation
efficiency for a neighboring CpG site located 8–10 bp further
(data not shown). This suggests that, at least in the context of our
experimental system, the proposed relationship between CpG
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spacing and DNA methylation efficiency [47] may not apply or
may be compounded by other effects. When compared to prior
studies examining possible site-preference by using purified
DNMT3A or DNMT3B proteins in in vitro methylation assays,
our results are in close agreement with data from Lin et al., (2002)
[29]. In this study, the authors reported that the full length murine
DNMT3A protein shows elevated activity at sites carrying
pyrimidines at positions 22 and +1. Such preference is in
remarkable agreement with our in vitro data using human
DNMT3A (Figure 2 and Figure S3) and is consistent with our in
vivo evidence. Our data are more difficult to reconcile with the data
of Handa et al. (2002) who used murine enzymes either full-length
or in a truncated C-terminal form and determined that both
DNMT3A and DNMT3B share a common preference for AT-
rich flanks and for certain palindromic sequences [28]. In our
study, flanks such as 59-ACGT-39 or other combinations of A/T
bases at the 21 and +1 positions, were consistently found around
or slightly below the median in terms of DNA methylation
efficiencies. This could represent a difference between murine and
human enzymes or between the experimental systems used.
Overall, our study demonstrates that the DNMT3A and
DNMT3B de novo DNMTs possess clear and distinct flanking
sequence preferences in vivo. Such preferences, while clearly
significant, remain sufficiently relaxed that they are compatible
with the methylation of a wide variety of CpG sites, as observed in
the genome. It should also be noted that only a portion of all
possible flanks have been examined here and that the ultimate
identities of the DNMT3A and DNMT3B signature motifs might
evolve upon surveying a more complete sequence space. However,
several lines of evidence suggest that the signature motifs described
here may have predictive value. For instance, we showed that
promoter-associated CpG islands showed a depletion for CpG sites
corresponding to predicted DNMT3B hotspots and an enrichment
for predicted coldspots. In contrast, a distinct set of CpG islands
which tend to associate with gene bodies and tend to be
methylated did not show evidence for such selection (Figure 6).
This suggests that the intrinsic sequence preference of DNMT3B
may have contributed to shaping the composition of CpG island
promoters to favor the maintenance of a state devoid of DNA
methylation. Likewise, we note that recent analysis of the complete
human methylome revealed that a T at the 22 position was
enriched in high methylation sites in the CHG and CHH context,
a type of non-CG methylation that is only observed in pluripotent
embryonic stem cells that are characterized by high de novo
methyltransferase activity [48]. This enrichment is consistent with
our motif assignments and with prior studies which implicated
DNMT3A in non-CG methylation activity [37,38].
In this study, we also investigated the effect of the DNMT3L
protein on the deposition of DNA methylation patterns. Two main
novel findings emerged. First, DNMT3L appears to direct de novo
methylation towards well-chromatinized DNA templates. This was
observed initially as a bias in the DNMT3L stimulatory effect in
favor of newly replicated DNA strands (Figure 8). A strand-tagging
experiment, however, allowed us to demonstrate that this bias was
not due to a direct coupling between DNMT3L-mediated DNA
methylation and DNA replication. This conclusion is expected
from the fact that DNMT3L mediates the deposition of DNA
methylation patterns in non-replicating cell types during germ cell
development [42]. We therefore suggest that DNMT3L may
require properly chromatinized DNA substrates for its function.
This proposal is consistent with the fact that DNMT3L binds to
histones directly [18,19]. In that context, the ‘‘replication’’ bias we
observed for DNMT3L likely reflected the necessity for replica-
tion-coupled nucleosome deposition to occur on newly transfected
episomes. Interestingly, DNMT3A and DNMT3B on their own
did not show any ‘‘replication’’ bias even though evidence clearly
suggests that these proteins bind to nucleosomes [49,50]. This
suggests that DNMT3L imposes an even stricter requirement for
well-chromatinized substrates onto the process of de novo DNA
methylation. Our second finding showed that while DNMT3L
does not appear to affect the intrinsic sequence preference of
DNMT3A and DNMT3B, its stimulatory effect is not felt
uniformly across CpG sites. On the contrary, our analysis revealed
a striking inverse relationship between the stimulation afforded by
DNMT3L and the initial DNA methylation efficiency by
DNMT3A or DNMT3B (Figure 8). Such an effect could again
result from the ability of DNMT3L complexes to associate with
chromatin, thus favoring the occupancy of DNA by DNMT3A
and DNMT3B. An increased DNA dwell time would greatly
increase the likelihood that a methylation coldspot will become
methylated without strongly affecting the outcome at a rapidly
methylated hotspot. This proposal is consistent with the observa-
tion that expression of DNMT3L appears to attenuate the impact
of intrinsic flanking sequence preferences of DNMT3A and
DNMT3B, lowering the range of individual methylation efficien-
cies between CpG sites (Figure S5) and triggering the deposition of
more uniform patterns characterized by longer methylation tracts
(compare Figures S3 and S4). This is in agreement with the in vivo
function of DNMT3L, which ensures that its multiple target
regions (interspersed repeats, satellite repeats, differentially
methylated imprinted regions and other chromosomal regions;
[15–17,51,52]) are fully methylated over long blocks of DNA
sequence. In that context, it is interesting to note that the drastic
reduction of DNA methylation observed in the absence of
DNMT3L at imprinting centers may reflect, at least in part, the
possibility that such sequences are strongly enriched in methyla-
tion coldspots. As discussed above for the SNRPN region studied
here, imprinting centers overlapping CpG islands tend to exhibit
strong GC skew (P.A.G. and F.C., unpublished data). Our data
suggests that the C-rich strand of such regions may be particularly
difficult to methylate, thus rendering the action of DNMT3L all
the more critical at these regions. Altogether, our study reports
that the catalytic activity of DNMT3A and DNMT3B show
significant and distinct flanking sequence preference in vivo and
suggests that the ability of DNMT3L to bind to chromatin, in
addition to its ability to stimulate the catalytic activity of
DNMT3A and DNMT3B, are key to its biological function.
Materials and Methods
Expression vectors, episomes, and target sequences
Full-length human DNMT3A, DNMT3A2, DNMT3B (the
DNMT3B1 isoform was used throughout, unless indicated) and
DNMT3L proteins were expressed in HEK293c18 cells using
previously described vectors [41].
The E. coli dcm methyltransferease gene (GenBank accession
number: YP_853012) was amplified from E. coli genomic DNA
(DH10B strain) with a forward primer containing an in-frame
EcoRI site (underlined) (DcmFOR: 59-TTTTTTGAATTCATG-
CAGGAAAATATATCAGT-39) and a reverse primer containing
a BamHI site (underlined) located immediately after the stop
codon (DcmREV: 59-TTTTTTGGATCCTTATCGTGAAC-
GTCGGCCAT-39). The amplified dcm PCR fragment was then
digested with EcoRI and BamHI, cloned into the corresponding
sites of pcDNA3/Myc [41] and sequence verified. A nuclear
localization signal (NLS) was subsequently cloned into the EcoRI
site in frame using two annealed oligonucleotides: 59-AATTCCC-
CAAGAAAAAGAGGAAAGTCC-39 and 59-GGGGTTCTTT-
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TTCTCCTTTCAGGTTAA-39. The resulting construct, pcDNA3/
Myc-dcm, expresses an N-terminally MYC-tagged version of
the E. coli Dcm methyltransferase carrying a functional NLS.
The pFC19 target episome was used as a methylation target and
has been previously described [40]. pFC19 contains the EBNA1/
OriP replication system derived from the Epstein-Barr virus and
can be stably maintained in mammalian cells. It carries a 940 bp
fragment from the differentially methylated region of the human
SNRPN CpG island. The first two regions to be analyzed
corresponded to sequences present on the episomal backbone,
namely: (1) a ,500 base-pair (bp) region of the pBR322 backbone
carrying 48 CpG sites; (2) a ,500 bp of the Hygromycin (Hygro)
resistance gene carrying 47 CpG sites. A ,300 bp region of the
SNRPN region carrying 23 CpG sites was also analyzed. An
additional ,500 bp region from the human TIMELESS CpG
island promoter was also cloned instead of the SNRPN sequence
and analyzed. All sequences are available in Text S1.
Cell culture, transfections, and DNA recovery
The HEK293 EBNA1 cell line (293c18, ATCC) was used in all
experiments and grown under standard conditions. Transfections
were performed using either the calcium phosphate method or
Turbofect (Fermentas). For each expression vector or episome,
500 ng of DNA was used per well of a 6-well plate. Cells were
allowed to grow for 2–3 days after transfection before being
transferred to a 100-mm diameter plate. Upon reaching
confluence (6–7 days), cells were harvested for episomal DNA
extraction according to the Hirt method [53]. No selection was
applied. All experiments were conducted at least in duplicate.
For experiments involving a stably replicating pFC19, the
episome was first introduced into HEK293c18 cells and the cells
were kept under selective pressure (200mg/ml Hygromycin) for
over 20 cell divisions. At this point, the pcDNA3/Myc-dcm
expression vector was transfected and expression of Dcm
methyltransferase was determined every day post-transfection by
Western blot using an Anti-MYC antibody (Sigma). Dcm was
clearly expressed as early as 24 hours after transfection and
expression remained strong for five days, at which point it dropped
rapidly (data not shown). The Dcm methyltransferase was clearly
active as judged from the fact that genomic DNA extracted 5 days
post-transfection was almost entirely resistant to EcoRII, an
enzyme that recognizes CC(A/T)GG sites and is sensitive to dcm
methylation. DNA from untransfected cells, by contrast, was
extensively cleaved (data not shown). Likewise, episomal DNA
harvested seven days post Dcm transfection clearly carried dcm
methylation as seen by bisulfite methylation sequencing (data not
shown). Seven days after transfection with pcDNA/Myc-dcm,
DNMT expression vectors in appropriate combinations were
introduced and the cells were allowed to grow for another 4–5
days until confluent, at which point episomal DNA was harvested.
In vitro DNA methylation reactions
In vitro methylation by the HhaI methyltransferase (New
England Biolabs) was performed as recommended by the supplier
and verified by restriction enzyme digestion. In vitro methylation by
DNMT3A was performed using purified recombinant Maltose-
Binding Protein (MBP)-tagged DNMT3A catalytic domain
(residues 590–912 of human DNMT3A). Reactions were per-
formed using 1mM MBP-DNMT3A and 250 ng of pFC19 DNA
in the presence of 100 mM S-adenosyl-L-methionine. The
reactions were incubated for 2 hours at 37uC, at which point
the proteins were removed by Proteinase K treatment followed by
phenol-chloroform extraction and ethanol precipitation.
Analysis of DNA methylation
Except when indicated, bisulfite methylation sequencing [32]
was used systematically to determine the methylation patterns
deposited by human de novo DNA methyltransferases. For this, the
Hirt DNA was first digested with PstI (New England Biolabs) to
linearize the DNA or, when desired, by EcoRII (Roche) to enrich
for molecules with dcm methylation. Cleavage was followed by
sodium bisulfite treatment as described [32] or using the EZ DNA
methylation-direct kit (Zymo research). Both strands of DNA were
subsequently PCR amplified from different regions of the episome
(primers available upon request) and the resulting PCR fragments
were cloned using the TopoTA cloning kit (Invitrogen). Single
colonies carrying individual DNA molecules were then picked and
plasmid DNA sequenced. The overall efficiency of bisulfite
conversion in this study was 99.1%. DNA methylation was also
analyzed using methylation sensitive restriction enzymes and
Southern blot analysis, as described [40]. In the case of the
TIMELESS and RNF168 sequences, bisulfite treatment was
combined to pyrosequencing in order to extract quantitative and
unbiased methylation patterns [54]. Pyrosequencing analysis was
conducted by EpigenDx (Worcester, MA).
Sequence analysis and statistical treatment
To handle and analyze the large amount of bisulfite sequencing
information generated in this study, we implemented in-house
software programmed in Visual Basic running under a Microsoft
Excel environment. The software input consists of a typical
ClustalW-type multiple alignment of trimmed sequence data (i.e..
the sequence corresponding to the region under analysis stripped
of flanking vector sequence). From this, the software automatically
computes the conversion efficiency for each molecule and filters
any molecule below a user-defined threshold (no less than 95%
conversion in all cases). It then calculates the distribution of
methylated and unmethylated CpG sites and reports the data as a
standard graph, as shown in Figure 2. The software also calculates
the overall methylation efficiency for each DNA molecule and for
each CpG site across the analyzed sample. This allows us to rank
the various CpG sites according to their individual methylation
efficiencies and to extract and align the sequences flanking each
CpG, focusing on the top 10% most methylated sites and bottom
10% least methylated sites or any other user-defined portion of the
distribution. A statistical test for the enrichment of a residue at any
given position above what is expected from the average
composition of the sequence being considered is also built-in
using a Chi-square test. The statistical significance of enrichment is
reflected by a P-value which is calculated from the distribution of
Chi-square values. This software is available upon request.
Enrichment plots were generated using the WebLogo application
package [55].
Analysis of the distribution of CpG motifs in the human
genome
The sequence sets used here correspond to all ‘‘specific’’ CpG
islands on human chromosome 1 as defined by Bock and
colleagues [39] and accessed from the hg18 build of the UCSC
Human Genome Browser (representing a total of 1,033 islands
and approximately 1 megabase of DNA sequence). The set of
‘‘weak’’ CpG islands was obtained from the same source but
corresponded to CpG islands that have no overlap with specific or
balanced CpG islands as defined by Bock and colleagues (a total of
906 islands representing approximately 0.45 megabase of DNA
sequence). To evaluate the exceptionality of motif frequencies, we
used the R’MES software (http://genome.jouy.inra.fr/ssb/rmes/).
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This software uses Markovian models to compute the expected
distribution of given sequence motifs in a sequence and compares it
to actual observations. The score reflects the over- or under-
representation of motifs under the model being used.
Supporting Information
Figure S1 Methylation patterns are similar between full length
DNMT3A and DNMT3B and their isoforms, DNMT3A2 and
DNMT3B2. For this analysis, the overall methylation pattern at
the pBR322 region was determined for each of the 48 CpG sites
by combining observations on both the top and bottom strands.
The total number of independent samples analyzed was 236 for
DNMT3A, 109 for DNMT3A2, 228 for DNMT3B, and 136 for
DNMT3B2. A. CpG sites were ranked according to their
individual methylation efficiencies. The ranks observed at each
of the 48 CpG sites were then plotted against each other for one
isoform versus the other, as indicated. A clear correlation was
observed, showing that the overall hierarchy of sites is not changed
(r2 values were 0.71 for DNMT3A and DNMT3A2 (left) and 0.78
for DNMT3B and DNMT3B2 (right)) B. The total number of
methylation events normalized to the average of each sample are
plotted at each CpG site along the pBR322 region for each
isoform. The patterns observed were clearly similar in that high
sites remained high and low sites remained low in each case.
Found at: doi:10.1371/journal.pgen.1001106.s001 (1.73 MB EPS)
Figure S2 High and low methylation efficiency sites at the
SNRPN test region (C-strand) conform to the sequence motifs
defined for DNMT3A and DNMT3B at the pBR and Hygro test
regions. High and low sites for DNMT3A show clear evidence for
selection at the 22 and +2 positions (highlighted in yellow)
according to the predictive motifs defined for DNMT3A (top
panel). Likewise, high and low sites for DNMT3B show clear
evidence for selection at the +1 position (highlighted in yellow)
according to the predictive motifs defined for DNMT3B.
Found at: doi:10.1371/journal.pgen.1001106.s002 (1.37 MB EPS)
Figure S3 A. This panel represents the DNA methylation
patterns deposited by purified full-length DNMT3A2 enzyme in
complex with DNMT3L, as measured by bisulfite methylation
sequencing. Symbols are as described above. B. The in vitro
flanking sequence preference for DNMT3A was determined by
focusing on the 10% most and least methylated sites observed in
panel A. Both top and bottom sites show evidence of selection for
particular residues at the 22 position, as was observed in vivo.
Found at: doi:10.1371/journal.pgen.1001106.s003 (1.60 MB EPS)
Figure S4 In vivo methylation patterns observed on the bottom
strand of the pBR322 region upon expression of DNMT3A (left)
or DNMT3A and DNMT3L (right). The arrows highlight the two
most distinct sites in terms of their methylation efficiencies for
DNMT3A.
Found at: doi:10.1371/journal.pgen.1001106.s004 (1.97 MB EPS)
Figure S5 DNMT3L promotes the formation of more uniform
DNA methylation patterns. The y-axis describes the overall range
of methylation efficiencies observed among 48 different CpG sites
on the pBR322 bottom strand. In all cases, the least methy-
lated site within a sample is given an arbitrary value of 1. The
whisker plot (box area comprises 75% of all values) shows that
DNMT3L significantly reduces the spread in methylation
efficiencies (***, pvalue,0.001 according to unpaired t-test).
Found at: doi:10.1371/journal.pgen.1001106.s005 (1.28 MB EPS)
Text S1 Sequence files for analyzed regions.
Found at: doi:10.1371/journal.pgen.1001106.s006 (0.03 MB
DOC)
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